Keyword Connections

immune checkpoint blockade (icb) therapy

Journals

0

No Journal Connected

Research Groups

0

No Research Group Connected

Bibliographies

1

1 Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC.